{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:12:44Z","timestamp":1787508764616,"version":"build-2736575974"},"reference-count":45,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T00:00:00Z","timestamp":1233187200000},"content-version":"vor","delay-in-days":3469,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1999,8]]},"abstract":"<jats:p>\n                    <jats:list list-type=\"explicit-label\">\n                      <jats:list-item>\n                        <jats:p>\n                          To determine how pretreatment with sulphonylureas alters the \u03b2 cell function, mouse islets were cultured (18\u201320\u2003h) without (controls) or with (test) 0.01\u2003\u03bc\n                          <jats:sc>M<\/jats:sc>\n                          glibenclamide. Acute responses to glucose were then determined in the absence of glibenclamide.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\n                          Test islets were insensitive to drugs (sulphonylureas and diazoxide) acting on K\n                          <jats:sup>+<\/jats:sup>\n                          \u2010ATP channels, and their [Ca\n                          <jats:sup>2+<\/jats:sup>\n                          ]\n                          <jats:sub>i<\/jats:sub>\n                          was already elevated in the absence of stimulation.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\n                          Insulin secretion was increased in the absence of glucose, and mainly stimulated between 0\u201310 instead of 7\u201320\u2003m\n                          <jats:sc>M<\/jats:sc>\n                          glucose in controls. The maximum response was halved, but this difference disappeared after correction for the 45% decrease in the islet insulin content.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\n                          The first phase of glucose\u2010induced insulin secretion was abrogated because of a paradoxical decrease of the high basal [Ca\n                          <jats:sup>2+<\/jats:sup>\n                          ]\n                          <jats:sub>i<\/jats:sub>\n                          in \u03b2 cells. The second phase was preserved but occurred with little rise of [Ca\n                          <jats:sup>2+<\/jats:sup>\n                          ]\n                          <jats:sub>i<\/jats:sub>\n                          . These abnormalities did not result from alterations of glucose metabolism (NADPH fluorescence).\n                        <\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\n                          In islets cultured with 50\u2003\u03bc\n                          <jats:sc>M<\/jats:sc>\n                          tolbutamide, glucose induced biphasic increases in [Ca\n                          <jats:sup>2+<\/jats:sup>\n                          ]\n                          <jats:sub>i<\/jats:sub>\n                          and insulin secretion. The decrease in the secretory response was matched by the decrease in insulin content (45%) except at maximal glucose concentrations. Islets pretreated with tolbutamide, however, behaved like those cultured with glibenclamide if tolbutamide was also present during the acute functional tests.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\n                          In conclusion, treatment with a low glibenclamide concentration causes long\u2010lasting blockade of K\n                          <jats:sup>+<\/jats:sup>\n                          \u2010ATP channels and rise of [Ca\n                          <jats:sup>2+<\/jats:sup>\n                          ]\n                          <jats:sub>i<\/jats:sub>\n                          in \u03b2 cells. Glucose\u2010induced insulin secretion occurs at lower concentrations, is delayed and is largely mediated by a modulation of Ca\n                          <jats:sup>2+<\/jats:sup>\n                          action on exocytosis. It is suggested that glucose regulation of insulin secretion mainly depends on a K\n                          <jats:sup>+<\/jats:sup>\n                          \u2010ATP channel\u2010independent pathway during\n                          <jats:italic>in vivo<\/jats:italic>\n                          sulphonylurea treatment.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>British Journal of Pharmacology<\/jats:italic>\n                    (1999)\n                    <jats:bold>127<\/jats:bold>\n                    , 1883\u20131891; doi:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"10.1038\/sj.bjp.0702731\">10.1038\/sj.bjp.0702731<\/jats:ext-link>\n                  <\/jats:p>","DOI":"10.1038\/sj.bjp.0702731","type":"journal-article","created":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T15:24:28Z","timestamp":1106925868000},"page":"1883-1891","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca\n                    <sup>2+<\/sup>\n                    regulation prevail over changes in insulin content"],"prefix":"10.1111","volume":"127","author":[{"given":"Marcello","family":"Anello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Claude","family":"Henquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1998.78.1.227"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(98)01225-9"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(92)90330-L"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02056108"},{"key":"e_1_2_7_6_1","first-page":"229","article-title":"Pharmacological interaction between tolbutamide and acetylsalicylic acid: study on insulin secretion in man","volume":"28","author":"CATTANEO A.G.","year":"1990","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118219"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4157(91)90012-L"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1997.399bh.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-113-6-1972"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116308"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115714"},{"key":"e_1_2_7_13_1","doi-asserted-by":"crossref","first-page":"20713","DOI":"10.1016\/S0021-9258(19)36744-4","article-title":"Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin secreting pancreatic B\u2010cell","volume":"267","author":"GILON P.","year":"1992","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.35.1.6"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.6.737"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1990.tb01771.x"},{"key":"e_1_2_7_17_1","first-page":"389","article-title":"Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in \u03b2\u2010cell\u2010rich pancreatic islets","volume":"105","author":"HELLMAN B.","year":"1984","journal-title":"Acta Endocrinol."},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/271271a0"},{"key":"e_1_2_7_19_1","first-page":"93","volume-title":"New Antdiabetic Drugs","author":"HENQUIN J.C.","year":"1990"},{"key":"e_1_2_7_20_1","first-page":"56","volume-title":"The Joslin's Diabetes Mellitus","author":"HENQUIN J.C.","year":"1994"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.139.3.993"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016321313510"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.46.5.808"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.11.1300"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.8.1266"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1296-1344"},{"key":"e_1_2_7_27_1","first-page":"298","article-title":"Impaired \u03b2\u2010cell function with chronic hyperglycemia: \u2018overworked \u03b2\u2010cell\u2019 hypothesis","volume":"4","author":"LEAHY J.L.","year":"1996","journal-title":"Diabetes Rev."},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W"},{"key":"e_1_2_7_29_1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2337\/diab.41.10.1221","article-title":"Electrophysiology of stimulus\u2010secretion coupling in human \u03b2\u2010cell","volume":"41","author":"MISLER S.","year":"1992","journal-title":"Diabetes"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90327-4"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-09127-2_6"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00172128"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmr.5610100104"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1340272"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.131.4.1815"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1994.266.6.E852"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.39.12.1580"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00625802"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02738684"},{"key":"e_1_2_7_40_1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2337\/diab.41.4.438","article-title":"Dual functional role of membrane depolarization\/Ca2+ influx in rat pancreatic \u03b2\u2010cell","volume":"41","author":"SATO Y.","year":"1992","journal-title":"Diabetes"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.140.5.2252"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.11.1713"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb16551.x"},{"key":"e_1_2_7_44_1","doi-asserted-by":"crossref","unstructured":"UK PROSPECTIVE DIABETES STUDY GROUP. (1998).Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes.Lancet 352 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"e_1_2_7_45_1","first-page":"S357","article-title":"The influence of cultivation on proinsulin biosynthesis and secretion of isolated pancreatic islets of C57BL\u2010mice, long\u2010term treated with glibenclamide in vivo","volume":"76","author":"WILKE B.","year":"1980","journal-title":"Endokrinologie"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00169252"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0702731","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0702731","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1038\/sj.bjp.0702731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T12:16:25Z","timestamp":1698495385000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1038\/sj.bjp.0702731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["10.1038\/sj.bjp.0702731"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjp.0702731","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8]]},"assertion":[{"value":"2009-01-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}